首页> 外文OA文献 >PCN147 Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast Cancer

【2h】

PCN147 Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast Cancer

机译：紫杉醇白蛋白，紫杉醇和多西紫杉醇作为转移性乳腺癌的二线治疗的PCN147经济评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Gharaibeh M.; Malone D.C.;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Nab-paclitaxel or docetaxel; as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): cost utility analysis from the perspective of the United Kingdom (UK) [J] . G.Dranitsaris, M.Lidgren, J.Lundkvist, European Journal of Cancer Supplements . 2008,第7期

机译：纳布紫杉醇或多西紫杉醇;作为传统紫杉醇治疗转移性乳腺癌（MBC）的替代品：英国（UK）的成本效用分析
2. Nab-paclitaxel or docetaxel; as alternatives to conventional paclitaxel for the treatment of metastatic breast cancer (MBC): cost utility analysis from the perspective of the United Kingdom (UK) [J] . G.Dranitsaris, M.Lidgren, J.Lundkvist, European Journal of Cancer Supplements . 2008,第7期

机译：纳布紫杉醇或多西紫杉醇;作为传统紫杉醇治疗转移性乳腺癌（MBC）的替代品：英国（UK）的成本效用分析
3. An economic evaluation of docetaxel and paclitaxel regimens in metastatic breast cancer in the UK. [J] . PharmacoEconomics . 2009,第10期

机译：英国多西紫杉醇和紫杉醇方案在转移性乳腺癌中的经济评估。
4. IG-001—A non-biologic micellar paclitaxel formulation for the treatment of metastatic Breast cancer [C] . Motamed Kouros, Hwang Larn, Hsiao Chao, IEEE International Conference on Nano/Molecular Medicine and Engineering . 2013

机译：IG-001—用于治疗转移性乳腺癌的非生物胶束紫杉醇制剂
5. Cost-Benefit Analysis of Nanoparticle Albumin-Bound Paclitaxel versus Solvent-Based Paclitaxel for the Treatment of Metastatic Breast Cancer in the United States [D] . Vichansavakul, Kittaya 2013

机译：纳米白蛋白结合紫杉醇与溶剂型紫杉醇在美国治疗转移性乳腺癌的成本效益分析
6. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity safety and quality of life [O] . Raffaella Palumbo, Federico Sottotetti, Giuseppe Trifirò, 2015

机译：纳米颗粒结合白蛋白的紫杉醇（nab-紫杉醇）作为HER2阴性紫杉烷预处理的转移性乳腺癌患者的二线化疗药物：对活性安全性和生活质量的前瞻性评估
7. Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa [O] . Abualbishr Alshreef, Kim MacQuilkan, Bryony Dawkins, 2019

机译：多西紫杉醇和紫杉醇治疗早期乳腺癌的成本效果：适应从英国到南非的模型的经济评估

PCN147 Economic Evaluation of Paclitaxel Albumin, Paclitaxel, and Docetaxel as a Second Line Treatment for Metastatic Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅